Delivery of DNA to tumor cells in vivo using adeno-associated virus.

Abstract

The number of published studies on transduction of tumor cells in vivo using recombinant adeno-associated virus (rAAV) vectors is very limited compared with those that have been published on targeting normal cells. A major reason for this can be attributed to the biology of the vector itself. AAV, being a nonpathogenic vector capable of providing transgene… (More)

Topics

  • Presentations referencing similar topics